Lipoic Acid Prevents the Changes of Intracellular Lipid Partitioning by Free Fatty Acid
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: It is suggested that the hepatic lipid composition is more important than lipid quantity in the pathogenesis of non-alcoholic steatohepatitis. We examined whether lipoic acid (LA) could alter intrahepatic lipid composition and free cholesterol distribution. Methods: HepG2 cells were cultured with palmitic acid (PA) with and without LA. Apoptosis, changes of the mitochondrial structure, intracellular lipid partitioning, and reactive oxygen species (ROS) activity were measured. Results: Free fatty acid (FA) increased apoptosis, and LA co-treatment prevented this lipotoxicity (apoptosis in controls vs PA vs PA+LA, 0.5% vs 19.5% vs 1.6%, p<0.05). LA also restored the intracellular mitochondrial DNA copy number (553±33.8 copies vs 291±14.55copies vs 421±21.05 copies, p<0.05) and reversed the morphological changes induced by PA. In addition, ROS was increased in response to PA and was decreased in response to LA co-treatment (41,382 relative fluorescence unit [RFU]vs 43,646 RFU vs 41,935 RFU, p<0.05). LA co-treatment increased the monounsaturated and polyunsaturated FA concentrations and decreased the total saturated FA fraction. It also prevented the movement of intracellular free cholesterol from the cell membrane to the cytoplasm. Conclusions: LA opposes free FA-generated lipotoxicity by altering the intracellular lipid composition and free cholesterol distribution
Abstract
Background/Aims: It is suggested that the hepatic lipid composition is more important than lipid quantity in the pathogenesis of non-alcoholic steatohepatitis. We examined whether lipoic acid (LA) could alter intrahepatic lipid composition and free cholesterol distribution. Methods: HepG2 cells were cultured with palmitic acid (PA) with and without LA. Apoptosis, changes of the mitochondrial structure, intracellular lipid partitioning, and reactive oxygen species (ROS) activity were measured. Results: Free fatty acid (FA) increased apoptosis, and LA co-treatment prevented this lipotoxicity (apoptosis in controls vs PA vs PA+LA, 0.5% vs 19.5% vs 1.6%, p<0.05). LA also restored the intracellular mitochondrial DNA copy number (553±33.8 copies vs 291±14.55copies vs 421±21.05 copies, p<0.05) and reversed the morphological changes induced by PA. In addition, ROS was increased in response to PA and was decreased in response to LA co-treatment (41,382 relative fluorescence unit [RFU]vs 43,646 RFU vs 41,935 RFU, p<0.05). LA co-treatment increased the monounsaturated and polyunsaturated FA concentrations and decreased the total saturated FA fraction. It also prevented the movement of intracellular free cholesterol from the cell membrane to the cytoplasm. Conclusions: LA opposes free FA-generated lipotoxicity by altering the intracellular lipid composition and free cholesterol distribution
참고문헌 (38)
- Cusi K, "Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications", Gastroenterology, 142, pp.711~725 (2012)
- Cusi K, "Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis", Clin Liver Dis, 13, pp.545~563 (2009)
- Fujii H, "Inflammation and fibrogenesis in steatohepatitis", J Gastroenterol, 47, pp.215~225 (2012)
- Mollica MP, "From chronic overfeeding to hepatic injury: role of endoplasmic reticulum stress and inflammation", Nutr Metab Cardiovasc Dis, 21, pp.222~230 (2011)
- Choudhury J, "Insulin resistance in NASH", Front Biosci, 10, pp.1520~1533 (2005)
- Haque M, "The metabolic abnormalities associated with non-alcoholic fatty liver disease", Best Pract Res Clin Gastroenterol, 16, pp.709~731 (2002)
- Park JH, "Insulin resistance in non-alcoholic fatty liver disease", Korean J Hepatol, 12, pp.16~30 (2006)
- Bugianesi E, "Insulin resistance: a metabolic pathway to chronic liver disease", Hepatology, 42, pp.987~1000 (2005)
- Polyzos SA, "Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines", Curr Mol Med, 9, pp.299~314 (2009)
- Yamaguchi K, "Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis", Hepatology, 45, pp.1366~1374 (2007)
- Amaro A, "Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia", Gastroenterology, 139, pp.149~153 (2010)
- Li ZZ, "Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase", J Biol Chem, 284, pp.5637~5644 (2009)
- Landry F, "Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors", J Lipid Res, 52, pp.1494~1499 (2011)
- Pan ZX, "Cloning and expression of stearoyl-CoA desaturase 1 (SCD-1) in the liver of the Sichuan white goose and landes goose responding to overfeeding", Mol Biol Rep, 38, pp.3417~3425 (2011)
- Mari M, "Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis", Cell Metab, 4, pp.185~198 (2006)
- Biewenga GP, "The pharmacology of the antioxidant lipoic acid", Gen Pharmacol, 29, pp.315~331 (1997)
- Packer L, "Alpha-lipoic acid as a biological antioxidant", Free Radic Biol Med, 19, pp.227~250 (1995)
- Mattulat A, "Determination of lipoic acid in meat of commercial quality", Z Lebensm Unters Forsch, 194, pp.326~329 (1992)
- Kataoka H, "Analysis of lipoic acid by gas chromatography with flame photometric detection", Methods Enzymol, 279, pp.166~176 (1997)
- Salinthone S, "Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS", Endocr Metab Immune Disord Drug Targets, 8, pp.132~142 (2008)
- Simbula G, "Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells", Apoptosis, 12, pp.113~123 (2007)
- Mijnhout GS, "Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials", Int J Endocrinol, 2012, pp.456279~ (2012)
- Papanas N, "alpha-Lipoic acid, diabetic neuropathy, and Nathan’s prophecy", Angiology, 63, pp.81~83 (2012)
- McIlduff CE, "Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy", Ther Clin Risk Manag, 7, pp.377~385 (2011)
- Gu XM, "Efficacy and safety of high-dose alpha-lipoic acid in the treatment of diabetic polyneuropathy", Zhonghua Yi Xue Za Zhi, 90, pp.2473~2476 (2010)
- Mijnhout GS, "Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?", Neth J Med, 68, pp.158~162 (2010)
- Xiang G, "alpha-lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose", Metabolism, 60, pp.480~485 (2011)
- Heinisch BB, "Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial", Eur J Clin Invest, 40, pp.148~154 (2010)
- Tardif JC, "Lipoic acid supplementation and endothelial function", Br J Pharmacol, 153, pp.1587~1588 (2008)
- "Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL", 6 mice, 2012, pp.90(5-6), 200~205[DOI]
- Serviddio G, "Mitochondrial dysfunction in nonalcoholic steatohepatitis", Expert Rev Gastroenterol Hepatol, 5, pp.233~244 (2011)
- "Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction", LIVER INTERNATIONAL, 31(9), pp.1315~1324 (2011), WILEY-BLACKWELL
- 임채영, "카르니틴이 비알코올성 지방간 질환에서 말초혈액 미토콘드리아 DNA 단위 반복수와 간기능에 미치는 영향", 대한소화기학회지, 55(6), pp.384~389 (2010), 대한소화기학회
- Maczurek A, "Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease", Adv Drug Deliv Rev, 60, pp.1463~1470 (2008)
- Valdecantos MP, "Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3", Obesity (Silver Spring), 20, pp.1974~1983 (2012)
- Celik S, "Effects of intraperitoneally administered lipoic acid, vitamin E, and linalool on the level of total lipid and fatty acids in guinea pig brain with oxidative stress induced by H2O2", J Biochem Mol Biol, 35, pp.547~552 (2002)
- Yilmaz O, "Effects of alpha lipoic acid, ascorbic acid-6-palmitate, and fish oil on the glutathione, malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin induced diabetic male rats", J Cell Biochem, 86, pp.530~539 (2002)
- Fernández A, "Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity", J Neurosci, 29, pp.6394~6405 (2009)